226 related articles for article (PubMed ID: 34911556)
1. Enhanced hepatic respiratory capacity and altered lipid metabolism support metabolic homeostasis during short-term hypoxic stress.
O'Brien KA; McNally BD; Sowton AP; Murgia A; Armitage J; Thomas LW; Krause FN; Maddalena LA; Francis I; Kavanagh S; Williams DP; Ashcroft M; Griffin JL; Lyon JJ; Murray AJ
BMC Biol; 2021 Dec; 19(1):265. PubMed ID: 34911556
[TBL] [Abstract][Full Text] [Related]
2. Futile cycle of β-oxidation and de novo lipogenesis are associated with essential fatty acids depletion in lipoatrophy.
Chaves-Filho AB; Peixoto AS; Castro É; Oliveira TE; Perandini LA; Moreira RJ; da Silva RP; da Silva BP; Moretti EH; Steiner AA; Miyamoto S; Yoshinaga MY; Festuccia WT
Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Mar; 1868(3):159264. PubMed ID: 36535597
[TBL] [Abstract][Full Text] [Related]
3. Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose.
Crescenzo R; Bianco F; Falcone I; Coppola P; Liverini G; Iossa S
Eur J Nutr; 2013 Mar; 52(2):537-45. PubMed ID: 22543624
[TBL] [Abstract][Full Text] [Related]
4. Palmitoleic Acid Decreases Non-alcoholic Hepatic Steatosis and Increases Lipogenesis and Fatty Acid Oxidation in Adipose Tissue From Obese Mice.
Cruz MM; Simão JJ; de Sá RDCC; Farias TSM; da Silva VS; Abdala F; Antraco VJ; Armelin-Correa L; Alonso-Vale MIC
Front Endocrinol (Lausanne); 2020; 11():537061. PubMed ID: 33117273
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis.
Shu Y; Hassan F; Coppola V; Baskin KK; Han X; Mehta NK; Ostrowski MC; Mehta KD
Mol Metab; 2021 Feb; 44():101133. PubMed ID: 33271332
[TBL] [Abstract][Full Text] [Related]
6. Branched-chain amino acids alter cellular redox to induce lipid oxidation and reduce de novo lipogenesis in the liver.
Surugihalli C; Muralidaran V; Ryan CE; Patel K; Zhao D; Sunny NE
Am J Physiol Endocrinol Metab; 2023 Apr; 324(4):E299-E313. PubMed ID: 36791321
[TBL] [Abstract][Full Text] [Related]
7. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE; Renquist BJ
J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of de novo lipogenesis by the IDH1 and IDH2-dependent reverse TCA cycle maintains the growth and angiogenic capacity of bone marrow-derived endothelial progenitor cells under hypoxia.
He Q; Yu T; Chen J; Liang J; Lin D; Yan K; Xie Z; Song Y; Chen Z
Free Radic Biol Med; 2024 Mar; 213():327-342. PubMed ID: 38281628
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol enrichment in liver mitochondria impairs oxidative phosphorylation and disrupts the assembly of respiratory supercomplexes.
Solsona-Vilarrasa E; Fucho R; Torres S; Nuñez S; Nuño-Lámbarri N; Enrich C; García-Ruiz C; Fernández-Checa JC
Redox Biol; 2019 Jun; 24():101214. PubMed ID: 31108462
[TBL] [Abstract][Full Text] [Related]
10. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
Musso G; Gambino R; Cassader M
Prog Lipid Res; 2009 Jan; 48(1):1-26. PubMed ID: 18824034
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
12. Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome.
Libby AE; Bales E; Orlicky DJ; McManaman JL
J Biol Chem; 2016 Nov; 291(46):24231-24246. PubMed ID: 27679530
[TBL] [Abstract][Full Text] [Related]
13. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
Crescenzo R; Bianco F; Coppola P; Mazzoli A; Tussellino M; Carotenuto R; Liverini G; Iossa S
Exp Physiol; 2014 Sep; 99(9):1203-13. PubMed ID: 24972835
[TBL] [Abstract][Full Text] [Related]
14. Azoxystrobin, a mitochondrial complex III Qo site inhibitor, exerts beneficial metabolic effects in vivo and in vitro.
Gao AH; Fu YY; Zhang KZ; Zhang M; Jiang HW; Fan LX; Nan FJ; Yuan CG; Li J; Zhou YB; Li JY
Biochim Biophys Acta; 2014 Jul; 1840(7):2212-21. PubMed ID: 24726979
[TBL] [Abstract][Full Text] [Related]
15. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia and fatty liver.
Suzuki T; Shinjo S; Arai T; Kanai M; Goda N
World J Gastroenterol; 2014 Nov; 20(41):15087-97. PubMed ID: 25386057
[TBL] [Abstract][Full Text] [Related]
17. Innate immune regulatory networks in hepatic lipid metabolism.
Bai L; Li H
J Mol Med (Berl); 2019 May; 97(5):593-604. PubMed ID: 30891617
[TBL] [Abstract][Full Text] [Related]
18. Hepatic mitochondrial energetics during catch-up fat after caloric restriction.
Crescenzo R; Bianco F; Falcone I; Prisco M; Dulloo AG; Liverini G; Iossa S
Metabolism; 2010 Aug; 59(8):1221-30. PubMed ID: 20045539
[TBL] [Abstract][Full Text] [Related]
19. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
Softic S; Cohen DE; Kahn CR
Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
[TBL] [Abstract][Full Text] [Related]
20. Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.
Ren LP; Chan SM; Zeng XY; Laybutt DR; Iseli TJ; Sun RQ; Kraegen EW; Cooney GJ; Turner N; Ye JM
PLoS One; 2012; 7(2):e30816. PubMed ID: 22355328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
